ArticleTrials2022

Effect of EARLY administration of DEXamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome (EARLY-DEX COVID-19): study protocol for a randomized controlled trial.

Anabel Franco-Moreno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.